Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality
Professor Maria Eriksdotter discusses whether Cholinesterase inhibitors are associated with slower cognitive decline and decreased mortality risk.
27 Huhti 20211min
Early Recognition of CNS complications During Treatment of MS
Dr. Martijn Wijburg discusses pharmacovigilance of patients treated with disease-modifying therapies for MS. Show references: https://pubmed.ncbi.nlm.nih.gov/33229453/
26 Huhti 20212min
Long-Term Survival of Participants in the CENTAUR Trial for ALS
Dr. Sabrina Paganoni discusses her abstract, "Long-Term Survival of Participants in the CENTAUR Trial of AMX0035 for ALS". You can view her abstract and others here: https://index.mirasmart.com/AAN202...
25 Huhti 20213min
Oral Rimegepant in Adults With Migraine and Cardiovascular Risk Factors
Dr. Susan Hutchinson discusses her abstract, "Oral Rimegepant 75 mg is Safe and Well Tolerated in Adults With Migraine and Cardiovascular Risk Factors: Results of a Multicenter, Long-Term, Open-Label ...
24 Huhti 20213min
Gender and Racial/Ethnic Diversity amongst Neurology Residents and Physicians
Dr. Fabiola Valenzuela discusses her abstract, "An Assessment of Gender and Racial/Ethnic Diversity amongst Neurology Residents and Physicians". You can view her abstract and others here: https://inde...
23 Huhti 20213min
Deep Brain Stimulation for Parkinson's Disease
Dr. Jill Ostrem discusses her abstract, "10 Year Clinical Outcomes of Subthalamic Nucleus versus Pallidal Deep Brain Stimulation for Parkinson's Disease". You can view her abstract and others here: ht...
22 Huhti 20213min
Gene Therapy in Leber Hereditary Optic Neuropathy
Dr. Nancy Newman discusses her abstract, "Evaluation of rAAV2/2-ND4 Gene Therapy Efficacy in Leber Hereditary Optic Neuropathy Using an External Control Group of Untreated Patients". You can view her ...
21 Huhti 20213min
Expanding the Spectrum of Chronic Immune Sensory Polyradiculopathy: CISP-Plus
Dr. Shahar Shelly discusses clinical, neurophysiological, and pathological features of CISP-plus in comparison to CISP. Show references: https://n.neurology.org/content/96/16/e2078
20 Huhti 20211min
